Inovio Pharmaceuticals, Inc. logo

Inovio Pharmaceuticals, Inc. (INO)

Market Closed
17 Jul, 20:00
NASDAQ (CM) NASDAQ (CM)
$
1. 12
0
0%
$
62.16M Market Cap
- P/E Ratio
- Div Yield
827,100 Volume
- Eps
$ 1.12
Previous Close
Add Transaction
Day Range
1.1 1.15
Year Range
1.03 2.98
Want to track INO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Name Ex-Dividend Date Dividend Payment Date Record Date Declaration Date Frequency
Inovio Pharmaceuticals, Inc. logo
INO Paid
Inovio Pharmaceuticals, Inc.
16 Oct 2017
28 Sep 2017
$0.07
16 Oct 2017
29 Sep 2017
21 Sep 2017
Other
Inovio Pharmaceuticals, Inc. logo
INO Paid
Inovio Pharmaceuticals, Inc.
15 Sep 2017
29 Aug 2017
$0.07
15 Sep 2017
31 Aug 2017
22 Aug 2017
Other
Inovio Pharmaceuticals, Inc. logo
INO Paid
Inovio Pharmaceuticals, Inc.
15 Aug 2017
27 Jul 2017
$0.07
15 Aug 2017
31 Jul 2017
25 Jul 2017
Other
Inovio Pharmaceuticals, Inc. logo
INO Paid
Inovio Pharmaceuticals, Inc.
17 Jul 2017
28 Jun 2017
$0.07
17 Jul 2017
30 Jun 2017
23 Jun 2017
Other

INO Dividend FAQ

What is the dividend yield?

There is currently no dividend yield for INO, as Inovio Pharmaceuticals, Inc is not paying dividends.

How often are dividends paid?

Inovio Pharmaceuticals, Inc is not making dividend payments, so there is no set payment schedule.

When is the next dividend payment date?

Inovio Pharmaceuticals, Inc has not announced any upcoming dividend.

What is the dividend history?

The company has a dividend payment history that includes 0 years of consistent payments. The most recent payment was $0.07 per share on 2017-09-28. For related earnings insights, visit the INO Earnings page.

What is the average annual dividend growth rate?

There is no dividend growth rate for INO, as Inovio Pharmaceuticals, Inc has not paid dividends in the past.

How can I track INO dividends?

You can easily track INO dividend payments using our Dividend Tracker. It helps you monitor upcoming payment dates, yields, history, and more - all in one place.